Organization name
Oncology
Alternate names
Oncology / Cancer
Country
Afghanistan


Results 1-4 of 4 (Search time: 0.002 seconds).

PreviewIssue DateTitleAuthor(s)
119-Jan-2025Patients' Perceptions of the Efficacy, Safety, and Quality of the Evidence of Medicinal Cannabis: A Survey of Australian Cancer PatientsFradgley, Elizabeth ABritton, Ben BrittonMartin, Jennifer HLucas, CatherineCarlson, Melissa ABridge, PaulaMorris, SarahWatts, GarethLynam, JamesTaylor, Joseph S 
216-Aug-2024Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III TrialGrimison, PeterMersiades, AntonyKirby, AdrienneTognela, AnnetteOlver, IanMorton, Rachael LHaber, PaulWalsh, AnnaLee, YvonneAbdi, EhteshamDella-Fiorentina, StephenAghmesheh, MortezaFox, PeterBriscoe, KarenSanmugarajah, JasothaMarx, GavinKichenadasse, GanessanWheeler, HelenChan, Matthew M K Shannon, JennyGedye, CraigBegbie, StephenSimes, R JohnStockler, Martin R
3May-2017The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaForsyth, Cecily J Fox, L.Cummins, K.D.Costello, B.Yeung, D.Cleary, R.Tatarczuch, M.Burbury, K.Motorna, O.Shortt, J.Fleming, S.McQuillan, A.Schwarer, A.Harrup, R.Holmes, A.Ratnasingam, S.Chan, K.L.Hsu, W.H.Ashraf, A.Putt, F.Grigg, A.
4Jun-2014Do screening trial recruitment logs accurately reflect the eligibility criteria of a given clinical trial? Early lessons from the RAVES 0803 trialSundaresan, Puma Turner, S.Kneebone, Andrew Pearse, M.Fraser-Browne, C.

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 1-15 of 15 (Search time: 0.005 seconds).

PreviewIssue DateTitleAuthor(s)
1Jan-2015Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanomaChan, Matthew M K Kefford, R.F.Carlino, M.Clements, A.Manolios, N.
2Sep-2015Clinical utility of ramucirumab in advanced gastric cancerChan, Matthew M K Sjoquist, K.M.Zalcberg, J.R.
3Nov-2015Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitorsChan, Matthew M K Menzies, A.M.Wilmott, J.S.Drummond, M.Lo, S.Lyle, M.Thompson, J.F.Guminski, A.Carlino, M.S.Scolyer, R.A.Kefford, R.F.Long, G.V.
4Aug-2017Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoringChan, Matthew M K Sabanathan, D.Zhang, A.Fox, P.Coulter, S.Gebski, V.Balakrishnar, B.Liddle, C.Gurney, H.
5Oct-2015Ipilimumab-induced hypophysitis in melanoma patients: an Australian case seriesChan, Matthew M K Lam, T.Sweeting, A.N.De Sousa, S.M.Clements, A.Carlino, M.S.Long, G.V.Tonks, K.T.Chua, E.Kefford, R.F.Chipps, D.R.
6Jul-2006Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary diseaseChan, Matthew M K Appleton, S.Poole, P.Smith, B.Veale, A.Lasserson, T.J.
7May-2018Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanomaChan, Matthew M K Lee, J.H.J.Lyle, M.Menzies, A.M.Lo, S.Clements, A.Cabral, N.L.Kefford, R.F.Long, G.V.
8Oct-2014The nature and management of metastatic melanoma after progression on BRAF inhibitors: effects of extended BRAF inhibitionChan, Matthew M K Haydu, L.E.Menzies, A.M.Azer, M.W.Klein, O.Lyle, M.Clements, A.Guminski, A.Kefford, R.F.Long, G.V.
916-Aug-2024Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III TrialGrimison, PeterMersiades, AntonyKirby, AdrienneTognela, AnnetteOlver, IanMorton, Rachael LHaber, PaulWalsh, AnnaLee, YvonneAbdi, EhteshamDella-Fiorentina, StephenAghmesheh, MortezaFox, PeterBriscoe, KarenSanmugarajah, JasothaMarx, GavinKichenadasse, GanessanWheeler, HelenChan, Matthew M K Shannon, JennyGedye, CraigBegbie, StephenSimes, R JohnStockler, Martin R
1019-Jan-2025Patients' Perceptions of the Efficacy, Safety, and Quality of the Evidence of Medicinal Cannabis: A Survey of Australian Cancer PatientsFradgley, Elizabeth ABritton, Ben BrittonMartin, Jennifer HLucas, CatherineCarlson, Melissa ABridge, PaulaMorris, SarahWatts, GarethLynam, JamesTaylor, Joseph S 
11Nov-2015A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trialChan, Matthew M K Davidson, A.Veillard, A.S.Hughes, B.G.Boyer, M.Briscoe, K.Begbie, S.Abdi, E.Crombie, C.Long, J.Boyce, A.Lewis, C.R.Varma, S.Broad, A.Muljadi, N.Chinchen, S.Espinoza, D.Coskinas, X.Pavlakis, N.Millward, M.Stockler, M.R.
12Oct-2020Platinum-containing regimens for triple-negative metastatic breast cancerChan, Matthew M K Egger, S.J.Luo, Q.Wilcken, N.
13Apr-2016sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistanceChan, Matthew M K Kaur, A.Webster, M.R.Marchbank, K.Behera, R.Ndoye, A.Kugel 3rd, C.H.Dang, V.M.Appleton, J.O'Connell, M.P.Cheng, P.Valiga, A.A.Morissette, R.McDonnell, N.B.Ferrucci, L.Kossenkov, A.V.Meeth, K.Tang, H.Y.Yin, X.Wood 3rd, W.H.Lehrmann, E.Becker, K.G.Flaherty, K.T.Frederick, D.T.Wargo, J.A.Cooper, Z.A.Tetzlaff, M.T.Hudgens, C.Aird, K.M.Zhang, R.Xu, X.Liu, Q.Bartlett, E.Karakousis, G.Eroglu, Z.Lo, R.S.Menzies, A.M.Long, G.V.Johnson, D.B.Sosman, J.Schilling, B.Schadendorf, D.Speicher, D.W.Bosenberg, M.Ribas, A.Weeraratna, A.T.
14Jul-2014Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma PatientsChan, Matthew M K Du Four, S.Hong, A.Charakidis, M.Duerinck, J.Wilgenhof, S.Wang, W.Feng, L.Michotte, A.Okera, M.Shivalingam, B.Fogarty, G.Kefford, R.Neyns, B.
15Jun-2015Taxane-containing regimens for metastatic breast cancerChan, Matthew M K Ghersi, D.Willson, M.L.Chan, M.M.Simes, J.Donoghue, E.